🇺🇸 FDA
Patent

US 8022202

Dihydrodiazepines useful as inhibitors of protein kinases

granted A61KA61K31/551A61K45/06

Quick answer

US patent 8022202 (Dihydrodiazepines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/551, A61K45/06, A61P, A61P11/00